NCT00376103View on ClinicalTrials.gov

Radiation Boost for Newly Diagnosed Glioblastoma Multiforme

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

March 31, 2008

Conditions
Glioblastoma Multiforme
Interventions
DRUG

temozolomide

75 mg/m2/day

PROCEDURE

Brachytherapy

60 Gy to 1 cm

PROCEDURE

External Beam Radiation Therapy

60 Gy

Trial Locations (1)

38104

Methodist University Hospital, Memphis

Sponsors
All Listed Sponsors
lead

Methodist Healthcare

OTHER

NCT00376103 - Radiation Boost for Newly Diagnosed Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter